Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men
- 1 September 1998
- journal article
- clinical trial
- Published by Wiley in British Journal of Urology
- Vol. 82 (3) , 373-379
- https://doi.org/10.1046/j.1464-410x.1998.00747.x
Abstract
Objective To determine the effects of terazosin on blood pressure and on antihypertensive therapy when used in managing benign prostatic hyperplasia (BPH). Patients and methods Safety data from a...Keywords
This publication has 33 references indexed in Scilit:
- A dose‐ranging study of the efficacy and safety of tamsulosin, the first prostate‐selective &agr;1A‐adrenoceptor antagonist*, in patients with benign prostatic obstructionBritish Journal of Urology, 1997
- Effects of alfuzosin on urethral and blood pressures in conscious male ratsLife Sciences, 1995
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United StatesArchives of internal medicine (1960), 1995
- Alpha1‐adrenoceptor subtypes in the human prostateBritish Journal of Urology, 1994
- Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study GroupArchives of Family Medicine, 1993
- The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- The efficacy and safety of terazosin for the treatment of symptomatic BPHThe Prostate, 1991
- Efficacy of once-A-day terazosin in benign prostatic hyperplasia: A randomized, double-blind placebo-controlled clinical trialThe Prostate, 1990
- Concomitant administration of terazosin and atenolol for the treatment of essential hypertensionArchives of internal medicine (1960), 1988